quinoxalines has been researched along with Hemophilia A in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kakizaki, S; Kanayama, Y; Ohnishi, H; Okamoto, H; Sato, K; Suga, T; Tojima, H; Uehara, D; Uraoka, T; Yamazaki, Y; Yanagisawa, K | 1 |
Botta, D; Brunet, P; Chambost, H; Delmotte, N; Falaise, C; Fedi, M; Henri, P; Jourde-Chiche, N; Lanot, A; PiƩtri, L; Robert, T; Verhelst, D; Von Kotze, C | 1 |
2 other study(ies) available for quinoxalines and Hemophilia A
Article | Year |
---|---|
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Genotype; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Japan; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Sulfonamides | 2021 |
[Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients].
Topics: Acute Kidney Injury; Antiviral Agents; Arteriovenous Shunt, Surgical; Benzofurans; Catheters, Indwelling; Diabetes Mellitus, Type 2; Drug Combinations; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nephrotic Syndrome; Quinoxalines; Renal Dialysis; Virus Replication | 2019 |